Maria Stamelou

Maria Stamelou is a Visiting Associate Professor in Neurology at the School of Medicine, European University of Cyprus. She holds academic qualifications including an Apl. Professor title from Philipps University, Marburg, Germany (2017), and a PhD in Neurology (2009) from the same institution. Her career includes roles as Principal Investigator in multiple neurology-related clinical trials and editorial leadership at the Movement Disorders Journal.

Her research focuses on neurodegenerative diseases, particularly Parkinsonian syndromes like Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). Key interests include clinical diagnosis criteria validation, neuroprotection strategies, and genetic Parkinsonism. Her work emphasizes translating pathological insights into clinical practice through biomarker development and trial design.

Dr. Stamelou has led high-impact studies published in Lancet Neurology and Mov Disord, addressing diagnostic challenges and therapeutic targets. She has received prestigious awards including the L’Oreal-UNESCO Women in Science Award (2019) and Fellowship from the European Academy of Neurology (since 2015). Her research projects include global initiatives like the Parkinson's Progression Markers Initiative (PPMI).

Her advisory roles include editorial duties for the Movement Disorders Journal and leadership in clinical trial networks. She has conducted over 12 clinical trials in Parkinson’s and PSP, demonstrating expertise in both basic science and translational research.